Close Menu

In a paper appearing in PLoS Genetics this week, a large team led by investigators at the University of Colorado at Boulder estimates that "the odds of schizophrenia increase by [around] 17 percent for every 1 percent increase in genome-wide autozygosity," based on its analysis of genome-wide SNP data from 9,388 cases and 12,456 controls.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Two COVID-19 vaccine developers have released their trial protocols to build public trust, the New York Times reports.

A new analysis finds the rapid COVID-19 test from DnaNudge to be highly accurate, Reuters reports.

In Science this week: global citizens' assembly on genome-editing technologies proposed, epigenetic markers predict metformin response, and more.

According to the Verge, many US states are not including positive results from rapid COVID-19 testing in their case numbers.